About
Nello Mainolfi is the Founder, President, and Chief Executive Officer of Kymera Therapeutics (NASDAQ: KYMR). He has held leadership roles in both large pharmaceutical companies and smaller biotech firms, with experience in company creation, team building, strategic partnering, and private and public offerings. At Kymera, his work is focused on developing a class of degrader medicines.
Founder at Kymera Therapeutics
Intro paths
→
In turn, Nello can intro founders to Kymera Therapeutics's investors below.
Kymera Therapeutics's investors · 10
Atlas VentureCambridge · $500K – $1M checksAvoro Capital AdvisorsNew YorkBain Capital Life SciencesBostonBessemer Venture PartnersRedwood City · $5M – $100M checksHatteras Venture PartnersResearch Triangle · $500K – $4M checksMRL Ventures FundCambridge · $25M checksNextech InvestZurich · $648K – $3.2M checksPfizer Venture Investments$5M – $20M checksSanofi VenturesCambridge · $5M checksSolasta VenturesBoston
Experience
- Kymera TherapeuticsFounder, President and Chief Executive Officercurrent2019 — present
- Kymera TherapeuticsFounder, President and Chief Scientific Officer2019Greater Boston Area
- Kymera TherapeuticsFounder and Chief Scientific Officer2019Greater Boston Area
- Kymera TherapeuticsFounder and Chief Technology Officer2017 — 2019Greater Boston Area
- Kymera TherapeuticsFounder and Vice President, Head of Drug Discovery2016 — 2017Greater Boston Area
- Atlas VentureAdvisorcurrent2018 — presentGreater Boston Area
- Atlas VentureEntrepeneur in Residence2016 — 2018Greater Boston Area
- Raze Therapeutics, Inc.Senior Director, Head of Drug Discovery2016Greater Boston Area
- Raze Therapeutics, Inc.Director, Head of Chemistry2015 — 2016Greater Boston Area
- Novartis Institutes for BioMedical ResearchSenior Investigator2013 — 2015Greater Boston Area
- Novartis Institutes for BioMedical ResearchInvestigator III2009 — 2013Greater Boston Area
- Novartis Institutes for BioMedical ResearchInvestigator II2007 — 2009Greater Boston Area
- The Scripps Research InstitutePostdoctoral Fellow2004 — 2007Greater San Diego Area
Skills & more
Drug Discovery99Medicinal Chemistry99Drug Design42Structure Based Drug Design11ADME16Drug Development58Ophthalmology12Angiogenesis8Immunology13Inflammation13Synthetic Organic Chemistry17Cheminformatics8
+12 more
High Throughput ScreeningSmall MoleculesTarget IdentificationOrganic SynthesisChemistryBiotechnologyOrganic ChemistryLife SciencesTeam LeadershipProject Team LeadershipHit to Clinical Candidate OptimizationFragment Based Drug DiscoveryFrom Nello's professional profile.
Frequently asked questions
- Who is Nello Mainolfi?
- Nello Mainolfi is the Founder, President, and Chief Executive Officer of Kymera Therapeutics (NASDAQ: KYMR). He has held leadership roles in both large pharmaceutical companies and smaller biotech firms, with experience in company creation, team building, strategic partnering, and private and public offerings. At Kymera, his work is focused on developing a class of degrader medicines.
- Where does Nello Mainolfi work?
- Nello Mainolfi is Founder of Kymera Therapeutics.
- What companies did Nello Mainolfi found?
- Nello Mainolfi founded Kymera Therapeutics.
- Where did Nello Mainolfi go to school?
- Nello Mainolfi studied at Imperial College London (PhD, Organic/Organometallic Synthetic Chemistry); Queen Mary University of London (BSc, Pharmaceutical Chemistry).
Same school
Also attended Imperial College London499
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 493 more
Also attended Queen Mary University of London69
Alix TricotInvestor at DaphniAlessandro De BenedettiAssociate at NorthzoneMoreno BonaventuraLead Machine Learning Engineer at Inreach VenturesLuisa VenturiniInvestor at CapitalGRachel MuzyczkaPartner, DMG Ventures at DMG VenturesAgnieszka VerletLegal at SC Ventures
+ 63 more
Shared employers
Also worked at Kymera Therapeutics5
Also worked at Atlas Venture61
Karim FarisInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesKristen LaguerreExecutive Partner at MPM BioImpactGretchen McCareyChief Financial Officer at Castle Island VenturesKate GunioController at Long Ridge Equity PartnersHenri MoissinacInvestor at FELIX CAPITAL
+ 55 more
Also worked at Raze Therapeutics, Inc.1
Also worked at Novartis Institutes for BioMedical Research130
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 124 more